Effects of a Resistance Training Program in Older Women With Sarcopenia
NCT ID: NCT02628145
Last Updated: 2023-10-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2015-08-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Power Training in Older Women With Pre-sarcopenia
NCT05870046
Combined Exercise and Nutrition Intervention for Possible Sarcopenia Among Older Adults in Primary Care
NCT06049914
Physical Activity Program for Counteracting Sarcopenia
NCT04172285
A Short-term Mixed Exercise for Sarcopenic Hospitalized Aged 80+ Years
NCT04355299
Auto-regulated Resistance-training for Older Adults
NCT05580913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Resistance Training Intervention
The RT intervention will take place three times per week for approximately 12 weeks on non-consecutive days using 8-10 exercises for major muscle groups utilizing free weights and machines follow American College of Sports Medicine and National Strength and Conditioning Association guidelines for RT in older adults.
Resistance Training Intervention
The RTI group will participate in a periodized RT program on 3 non-consecutive days/week using NSCA and ACSM guidelines and will be designed by a team member who is a NSCA certified strength and conditioning specialist. This program will consist of a full-body, nonlinear periodized program: a training method that has frequent variations in program variables. Intensity variations intensity are based on training phase. E.g., the first portion of 12-week cycle has more moderate and light days as participants adapt to the program. Weeks 1-4 will consist of primarily RT machine exercises and few unilateral and multi-joint light free weight exercise. Weeks 5-8 will incorporate more free-weight exercises that are multi-joint. Weeks 9-12 will incorporate more complex multi-joint movements.
Active Control Group
The CON group will meet three times weekly for approximately 12 weeks for light physical activity and stretching.
Active Control Group
The CON group will meet three times weekly for approximately 12 weeks for light physical activity and stretching.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistance Training Intervention
The RTI group will participate in a periodized RT program on 3 non-consecutive days/week using NSCA and ACSM guidelines and will be designed by a team member who is a NSCA certified strength and conditioning specialist. This program will consist of a full-body, nonlinear periodized program: a training method that has frequent variations in program variables. Intensity variations intensity are based on training phase. E.g., the first portion of 12-week cycle has more moderate and light days as participants adapt to the program. Weeks 1-4 will consist of primarily RT machine exercises and few unilateral and multi-joint light free weight exercise. Weeks 5-8 will incorporate more free-weight exercises that are multi-joint. Weeks 9-12 will incorporate more complex multi-joint movements.
Active Control Group
The CON group will meet three times weekly for approximately 12 weeks for light physical activity and stretching.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Low lean mass and/or low physical functioning based on current guidelines;
* Currently (≥ 6 months) not engaged in a regular exercise program;
* Post-menopausal by self-report.
Exclusion Criteria
* Significant or suspected cognitive impairment;
* Severe hearing loss, speech disorder, language barrier or visual impairment;
* Progressive, degenerative neurologic disease;
* Terminal illness with life expectancy of \< 12 months, as determined by a physician;
* Severe pulmonary disease, uncontrolled diabetes, blood pressure, or anemia;
* Medications not taken for \> 3 weeks, lipid lowering medications for \> 6 months;
* Major joint, vascular, abdominal, or thoracic surgery within six months;
* Significant cardiovascular disease or implanted pacemaker/defibrillator;
* Inability to safely engage in mild to moderate exercise with muscular exertion.
65 Years
84 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Rhode Island
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthew J. Delmonico, PhD, MPH
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mattthew J Delmonico, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Rhode Island
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rhode Island
Kingston, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HU1415-168
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.